Relevance of motor complications in Parkinson's disease

Neurology
Charles H Adler

Abstract

Although patients with Parkinson's disease usually respond to dopaminergic therapy with a smooth, continued effect when medication is first initiated, many patients eventually develop a fluctuating response along with involuntary movements (dyskinesias). The fluctuations in motor response often result in patients requiring more frequent dosing of medication that is less convenient, and they begin to lose control of their daily life. Their ability to work or to perform activities of daily living may fluctuate with response to medication, and the involuntary movements may interfere with activities. The fluctuations and dyskinesias can be painful and quite embarrassing. Overall, quality of life suffers. In addition, there is a marked increase in the expense to both the patient and society when motor fluctuations and dyskinesias develop.

Citations

Feb 7, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giovanni AbbruzzeseDelia Colombo
Oct 6, 2012·Journal of Medical Economics·Francesc ValldeoriolaUNKNOWN Workgroup of the SCOPE study
Jan 26, 2010·Expert Opinion on Drug Delivery·Ndidi NgwulukaDinesh Naidoo
Jun 30, 2006·Expert Opinion on Pharmacotherapy·Fabrizio Stocchi
Feb 21, 2009·Current Medical Research and Opinion·Rajesh Pahwa, Kelly E Lyons
Oct 2, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mark A StacyKurt Kroenke
Jun 15, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Theresa A ZesiewiczRobert A Hauser
Oct 18, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Alexei Korchounov, Gregory Bogomazov
Oct 2, 2014·Parkinsonism & Related Disorders·A RizosUNKNOWN EUROPAR and the IPDMDS non-Motor PD Study Group
Nov 22, 2005·Chronobiology International·Samir Câmara MagalhãesVeralice Meireles Sales de Bruin
Apr 20, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Peter A LeWittKarl D Kieburtz
Nov 28, 2013·Parkinsonism & Related Disorders·F StocchiUNKNOWN DEEP study group
Jun 28, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P DamierK Rerat
Oct 3, 2007·Clinical Neuropharmacology·Pablo Martínez-MartínXavier Badia
Nov 28, 2018·Expert Opinion on Drug Metabolism & Toxicology·Fabrizio StocchiMargherita Torti
Apr 14, 2007·Journal of the American Academy of Nurse Practitioners·Charlene Hoffman Snyder, Charles H Adler
May 7, 2019·Expert Opinion on Pharmacotherapy·Thomas MüllerJan-Dominique Möhr
Mar 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martinez-MartinUNKNOWN ValidQUICK Study Group
Jul 25, 2019·Drugs·Thomas Müller, Jan-Dominique Möhr
Oct 14, 2016·Science Translational Medicine·Michael M LippMartin I Freed
Feb 6, 2020·Expert Review of Clinical Pharmacology·Rita Moiron SimõesJoaquim J Ferreira
Jul 14, 2017·Frontiers in Aging Neuroscience·Luxi WangTao Wang
Jun 5, 2019·Drugs & Aging·Harsh V GuptaRajesh Pahwa
Feb 26, 2021·Expert Opinion on Pharmacotherapy·Fabrizio StocchiMargherita Torti
Dec 18, 2021·Neurodegenerative Disease Management·Thomas Müller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Parkinsonism & Related Disorders
Fabrizio StocchiDEEP study group
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Giovanni AbbruzzeseDelia Colombo
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
P A SilburnLilie Herawati
© 2022 Meta ULC. All rights reserved